T1266
Ausschreibungsinformationen
TED EULisboa, Portugal
- Art
- 29
- Verfahren
- restricted
- Referenznummer
- 736400-2024
- Geschätzter Wert
- 88,847 EUR
- CPV
- 33652000
Tocilizumab [162 Mg/0.9 Ml; Sol Inj; Seringa]
Lisboa, Portugal
Tocilizumab [162 Mg/0.9 Ml; Sol Inj; Seringa]